Evidence map›Paper›PMID 30183325›Full record

ArticleAmerican journal of respiratory cell and molecular biology2019

The Effects of IFN-λ on Epithelial Barrier Function Contribute to Klebsiella pneumoniae ST258 Pneumonia.

Danielle Ahn, Matthew Wickersham, Sebastian Riquelme, Alice Prince

Open access · greenAbstract read
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Microbiota-dependent IFN-L controls uterine and placental immunity.bioRxiv : the preprint server for biology · 2026
    Article
  7. Article
  8. Angiotensin-(1-7) treatment improves pneumonia and prevents sepsis caused by pneumococcal infection.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Article
  9. Article
  10. Article
  11. Interferon Lambda: The Next Frontier in Antiviral Therapy?Pharmaceuticals (Basel, Switzerland) · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Autophagy, cell death, and cytokines inEmerging microbes & infections · 2023
    Review
  20. Roles and Effects of Interferon Lambda Signaling in the Context of Bacterial Infections.Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Danielle AhnDepartment of Pediatrics, Columbia University College of Physicians and Surgeons, New York, New York.
Matthew WickershamDepartment of Pediatrics, Columbia University College of Physicians and Surgeons, New York, New York.
Sebastian RiquelmeDepartment of Pediatrics, Columbia University College of Physicians and Surgeons, New York, New York.
Alice PrinceDepartment of Pediatrics, Columbia University College of Physicians and Surgeons, New York, New York.ORCID 0000-0002-7399-9295
Columbia University · US

Funding

Tumor Biology and Microenvironment ProgramP30CA013696 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Parisa Tehranifar · 1985 to 2026
$115.3M
Innate Immune Clearance of Host-Adapted Pulmonary PathogensR35HL135800 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI PRINCE, ALICE S · 2017 to 2023
$5.9M
Host-pathogen interactions that promote carbapenem-resistant Klebsiella pneumoniae pulmonary infectionK08HL138289 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI AHN, DANIELLE · 2017 to 2021
$734k
Becton Dickinson LSR II Analytical Flow CytometerS10RR027050 · NCRR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CLYNES, RAPHAEL A. · 2011 to 2011
$413k
NCI NIH HHS P30 CA013696NCRR NIH HHS S10 RR027050NHLBI NIH HHS K08 HL138289NHLBI NIH HHS R35 HL135800
6 · The paper itself

Abstract

IFN-λ and IL-22, cytokines that share the coreceptor IL-10RB, are both induced over the course of Klebsiella pneumoniae ST258 (KP35) pneumonia. IL-22 is known to protect mucosal barriers, whereas the effects of IFN-λ on the mucosa are not established. We postulated that IFN-λ plays a role in regulating the airway epithelial barrier to facilitate cellular trafficking to the site of infection. In response to IFN-λ, the transmigration of neutrophils across a polarized monolayer of airway epithelial cells was increased, consistent with diminished epithelial integrity. KP35 infection increased epithelial permeability, and pretreatment with IFN-λ amplified this effect and facilitated bacterial transmigration. These effects of IFN-λ were confirmed in vivo, in that mice lacking the receptor for IFN-λ (Ifnlr1

Indexed as

AnimalsBacteremiaBronchiBronchoalveolar Lavage FluidEpithelial CellsFemaleHost-Pathogen InteractionsHumansInterferon LambdaInterferonsInterleukin-10 Receptor beta SubunitInterleukin-22InterleukinsKlebsiella InfectionsKlebsiella pneumoniaeMaleIFNLR1 protein, mouseInterferon Lambdainterferon-lambda, humanInterferonsInterleukin-10 Receptor beta SubunitInterleukin-22InterleukinsReceptors, Interferonairway epithelial barrierbacterial pneumoniaIFN-λIL-22

Identifiers

PMID30183325
PMCPMC6376406
OpenAlexW2891817413

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.